-
First COVID-19 vaccine clinical trial approved in India
europeanpharmaceuticalreview
July 01, 2020
Indian authorities have given the green light to test Bharat Biotech’s COVID-19 vaccine in Phase I and Phase II clinical trials.
-
Genetics has revolutionised patient selection for clinical trials
expresspharma
July 01, 2020
How is genetics improving the sphere of drug discovery and development? In what ways has it helped in clinical research, target identification, drug safety testing, etc.? Give us a few real-world examples.
-
Ampio to Start First Clinical Trial in COVID-19 Program
americanpharmaceuticalreview
June 30, 2020
Ampio Pharmaceuticals is developing therapies for patients infected with the SARS-CoV-2 virus (COVID-19).
-
Chinese firm says coronavirus vaccine candidate shows promise in human test
expresspharma
June 30, 2020
The experimental shot, developed by a Beijing-based unit of CNBG, has induced high-level antibodies in all the inoculated participants in a Phase 1/2 clinical trial involving 1,120 healthy people.
-
FDA announces first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials
worldpharmanews
June 29, 2020
The U.S. Food and Drug Administration launched Project Patient Voice, an initiative of the FDA’s Oncology Center of Excellence (OCE).
-
Over 2,000 clinical trials currently underway for COVID-19 therapies, finds study
europeanpharmaceuticalreview
June 28, 2020
New findings have revealed that over 2,000 clinical trials are being conducted to test COVID-19 therapies while 583 companies are involved in treatment and vaccine development.
-
Clinical trial disruption from COVID-19 beginning to lessen, says report
europeanpharmaceuticalreview
June 22, 2020
New findings reveal that the 200 clinical trials impacted and delayed by COVID-19 are now continuing or have completed their course.
-
TRV027 to be tested as COVID-19 illness treatment in clinical trial
europeanpharmaceuticalreview
June 17, 2020
A clinical trial is set to investigate whether a molecule known as TRV027 is effective at preventing lung damage and the formation of blood clots in COVID-19 patients.
-
Regeneron Begins Clinical Trials of Anti-Viral Antibody Cocktail
contractpharma
June 16, 2020
REGN-COV2 is targeted specifically against SARS-CoV-2.
-
Lonza Introduces Capsugel DBcaps Double-blinded Capsules
contractpharma
June 16, 2020
Designed to be used as an over-encapsulation tool during clinical phases to overcome blinding challenges.